Beneficial role of dietary phytoestrogens in obesity and diabetes

American Journal of Clinical Nutrition

Volumn 76, Issue 6, 2002, Pages 1191-1201

  Bhathena, Sam J ^a   Velasquez, Manuel T ^b  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidative actions; Diabetes mellitus; Diet; Flaxseed; Glucose; Hyperlipidemia; Insulin resistance; Isoflavones; Lignans; Obesity; Pancreatic cells; Phytoestrogens; Soy protein; Soybean

Indexed keywords

ANTIOXIDANT; DAIDZEIN; ESTROGEN RECEPTOR; GENISTEIN; GLUCOSE; INSULIN; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; MATAIRESINOL; PHYTOESTROGEN; SECOISOLARICIRESINOL; SOYBEAN PROTEIN;

CHRONIC DISEASE; DIABETES MELLITUS; DIETARY INTAKE; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LINSEED; METABOLIC REGULATION; NONHUMAN; OBESITY; PROTEIN INTAKE; REVIEW; WEIGHT REDUCTION;

ANIMALIA; GLYCINE MAX;

EID: 0036895683     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/76.6.1191     Document Type: Review

References (115)

1. Adlercreutz H, Mazur W. Phyto-oestrogens and western diseases. Ann Med 1997:2:95-120.
2. Anderson JJB, Garner SC. Phytoestrogens and bone. Balliere's Clin Endocrinol Metab 1998;12:543-57.
3. Setchell KDR. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68(suppl):1333S-48S.
4. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: Potential mechanisms. Am J Clin Nutr 1998;68(suppl):1390S-3S.
5. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-35.
6. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403-10.
7. Velasquez MT, Bhathena SJ. Dietary phytoestrogens: A possible role in renal disease protection. Am J Kidney Dis 2001;37:1056-68.
8. Ranich T, Bhathena SJ, Velasquez MT. Protective effects of phytoestrogens in chronic renal disease. J Renal Nutr 2001;11:183-93.
9. FDA. Food labeling health claims: Soy protein and coronary heart disease. Food and Drug Administration. Final rule. Fed Regist 1999;64:57700-33.
10. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978;103:1860-7.
11. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996; 17:271-5.
12. Kuiper GGJM, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-63.
13. Miksicek RJ. Interaction of naturally occurring non-steroidal estrogens with expressed with recombinant human estrogen receptor. J Steroid Biochem Mol Biol 1994;49:153-60.
14. Ross Barcelo A. Lignification in plant cell walls. In: Jeon KW, ed. International Review of Cytology. San Diego: Academic Press, 1997:87-132.
15. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
16. US Department of Agriculture Nutrient Data Laboratory. USDA-Iowa State University Database on the Isoflavone Content of Foods, Release 1.3. 2002. Internet: http://www.nal.usda.gov/fnic/foodcomp/data/isoflav/isoflav.html (accessed 28 August 2002).
17. Axelson M, Sjovall J, Gustafsson BE, Setchell KD. Soya - A dietary source of the non-steroidal oestrogen equol in humans and animals. J Endocrinol 1984;102:49-56.
18. Coward L, Barnes NC, Setchell KDR, et al. Genistein and daidzein, and their β-glycoside conjugates: Anti-tumor isoflavones in soy bean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
19. Wang H-J, Murphy PA. Isoflavone composition of American and Japanese soybean in Iowa: effects of variety, crop year, and location. J Agric Food Chem 1994;42:1674-7.
20. Haytowitz DB, Matthews RH. Legumes and Legume Products. Washington, DC: US Department of Agriculture, 1986:1-156.
21. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc 1991;91:828-35.
22. Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 1998;12:729-42.
23. Mazur WM, Uehara M, Wahala K, Adlercreutz H. Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br J Nutr 2000;83:381-7.
24. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52.
25. Slavin JL, Jacobs D, Marquart L. Grain processing and nutrition. Crit Rev Food Sci Nutr 2000;40:309-26.
26. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 1994;142:251-9.
27. Xu X, Wang H-J, Murphy PA, et al. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994;124:825-32.
28. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998;67:867-72.
29. Watanabe S, Yamaguchi M, Sobue T, et al. Pharmacokinetics of soybean isoflavones in plasma, urine, and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 1998;128:1710-5.
30. Xu X, Wang H-J, Murphy PA, Hendrich S. Neither background diet nor type of soy food affect short-term isoflavone bioavailability in women. J Nutr 2000;130:798-801.
31. Adlercreutz H, Fotsis T, Lampe J, et al. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 1993;53(suppl):5-18.
32. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-10.
33. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am J Clin Nutr 1991;54:1093-100.
34. Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual habits. J Steroid Biochem 1986;25:791-7.
35. Kirkman LM, Lampe JW, Campbell DR, et al. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer 1995;24:1-12.
36. Rickard SE, Orcheson LJ, Seidl MM, et al. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 1996;126:2012-9.
37. Tsai AC, Mott EL, Owen GM, et al. Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humans. Am J Clin Nutr 1983;38:504-11.
38. Ahmed M, Gannon MC, Nuttall FQ. Postprandial plasma glucose, insulin, glucagon and triglyceride response to a standard diet in normal subjects. Diabetologia 1976;12:61-7.
39. Sanchez A, Hubbard RW. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypoth 1991;36:27-32.
40. Howe JC. Postprandial response of calcium metabolism in postmenopausal women to meals varying in protein level/source. Metabolism 1990;39:1246-52.
41. Lang V, Bellisle F, Opper J-M, et al. Satiating effect of proteins in healthy subjects: A comparison of egg albumin, casein, gelatin, pea protein, and wheat gluten. Am J Clin Nutr 1998;67:1197-204.
42. Lang V, Bellisle F, Alamowitch C, et al. Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Eur J Clin Nutr 1999;53:959-65.
43. Forsythe WA III. Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentrations in the gerbil (Merones unguiculatus). J Nutr 1986;116:1165-71.
44. Beynen AC, West CE, Spaaij CJ, et al. Cholesterol metabolism, digestion rates and postprandial changes in serum of swine fed purified diets containing either casein or soybean protein. J Nutr 1990;120:422-30.
45. Scholz-Ahrens KE, Hagemeister H, Unshelm J, et al. Response of hormones modulating plasma cholesterol to dietary casein or soy protein in minipigs. J Nutr 1990;120:1387-92.
46. Lavigne C, Marette A, Jacques H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 2000;278:E491-500.
47. Wagner JD, Cefalu WT, Anthony MS, et al. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgous monkeys. Metabolism 1997;46:698-705.
48. Bhathena SJ. Dietary fatty acids and fatty acid metabolism in diabetes. In: Chow CK, ed. Fatty Acids in Foods and Their Health Implications. 2nd Ed. New York: Marcel Dekker, 2000:915-61.
49. Bosello O, Cominacini L, Zocca I, et al. Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab 1998;32:206-14.
50. Yamashita T, Sasahara T, Pomeroy SE, Collier G, Nestel PJ. Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 1998;47:1308-14.
51. Jenkins DJA, Wolever TMS, Spiller G, et al. Hypocholesterolemic effect of vegetable protein in a hypocaloric diet. Atherosclerosis 1989;78:99-107.
52. Mikkelsen PB, Toubro S, Astrup A. Effect of fat-reduced diets on 24-h energy expenditure: Comparisons between animal protein, vegetable protein, and carbohydrate. Am J Clin Nutr 2000;72:1135-41.
53. Saito M. Effect of soy peptides on energy metabolism in obese animals. Nutr Sci Soy Protein 1991;12:91-4.
54. Aoyama T, Fukui K, Takamatsu K, et al. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 2000;16:349-54.
55. Kawano-Takahashi Y, Ohminami H, Okuda H, et al. Effect of soya saponins on gold thioglucose-induced obesity in mice. Int J Obes 1986;10:293-302.
56. Fisler JS, Drenick EJ, Yoshimura NN, Swendseid ME. Plasma concentration of amino acids in obese men consuming low-calorie diets composed of soy or collagen protein. Int J Obes 1985;9:335-46.
57. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular risk factors in postmenopausal women. J Nutr 2001;131:1202-6.
58. Aoyama T, Fukui K, Nakamori T, et al. Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 2000;64:2594-600.
59. Kagawa K, Matsutaka H, Fukuhama C, et al. Globin digest, acidic protease hydrolysate, inhibits dietary hypertriglyceridemia and Val-Val-Tyr-Pro, one of its constituents, possesses most superior effect. Life Sci 1996;58:1745-55.
60. Ishihara K, Matsumoto K, Uohashi R, Fushiki T. Effect of soybean peptide on suppression of body fat accumulation during endurance swimming in mice. Nutr Sci Soy Protein 1996;17:94-7.
61. Hurley C, Galibois I, Jacqes H. Fasting and post-prandial lipid and glucose metabolisms are modulated by dietary proteins and carbohydrates: Role of plasma insulin concentrations. J Nutr Biochem 1995; 6:540-6.
62. Sugano M, Ishiwaki N, Nagata Y, Imaizumi K. Effects of arginine and lysine addition to casein and soya-bean protein on serum lipids, apolipoproteins, insulin and glucagon in rats. Br J Nutr 1982;48:211-21.
63. Baba N, Radwan H, Van Itallie T. Effects of casein versus soyprotein diets on body composition and serum lipid levels in adult rats. Nutr Res 1992;12:279-88.
64. Makino S, Nakashima H, Minami K, et al. Bile acid-binding protein from soybean seed: Isolation, partial characterization and insulin-stimulating activity. Agric Biol Chem 1988;52:803-9.
65. Minami K, Moriyama R, Kitagawa Y, Makino S. Identification of soybean protein components that modulate the action of insulin in vitro. Agric Biol Chem 1990:54:511-7.
66. Iritani N, Sugimoto T, Fukuda H. Dietary soybean protein increases insulin receptor gene expression in male Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 1997;127:1077-83.
67. Hurley C, Richard D, Deshaies Y, Jacques H. Soy protein isolate in the presence of cornstarch reduces body fat gain in rats. Can J Physiol Pharmacol 1998;76:1000-7.
68. Hermansen K, Sondergaard M, Hoie L, et al. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001;24:228-33.
69. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998,68(suppl):1347S-53S.
70. Tsai AC, Vinik AI, Lasichak A, Lo GS. Effects of soy polysaccharide on postprandial glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr 1987;45:596-601.
71. Mahalko JR, Sandstead HH, Johnson LK, et al. Effect of consuming fiber from corn bran, soy hulls, or apple powder on glucose tolerance and plasma lipids in type II diabetes. Am J Clin Nutr 1984;39:25-34.
72. Reddy S, Bibby NJ, Wu D, et al. A combined casein-free-nicotinamide diet prevents diabetes in the NOD mouse with minimum insulitis. Diabetes Res Clin Pract 1995:29:83-92.
73. Taha SA, Wasif MM. Hypoglycemic effect and protein nutritive quality of soy and methionine supplemented whole durum pasta products. Nahrung 1996;40:281-7.
74. Ikeda A, Sugano M. Interaction of dietary protein and alpha-linolenic acid on polyunsaturated fatty acid composition of liver microsomal phospholipids and eicosanoid production in streptozotocin induced diabetic rats. Ann Nutr Metab 1993;37:101-9.
75. Atkinson MA, Winter WE, Skordis N, et al. Dietary protein restriction reduces the frequency and delays the onset of insulin dependent diabetes in BB rats. Autoimmunity 1998;2:11-9.
76. Fort P, Lanes R, Dahlem S, et al. Breast feeding and insulin-dependent diabetes mellitus in children. J Am Coll Nutr 1986;5:439-41.
77. Virtanen SM, Aro A. Dietary factors in the etiology of diabetes. Ann Med 1994;26:469-78.
78. Demonty I, Deshaies Y, Jacques H. Dietary proteins modulate the effects of fish oil on triglyceridemia in the rat. Lipids 1998;33:913-21.
79. Jurowska J, Grondin G, Masse S, Morisset J. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats. Gastroenterology 1992;102:550-62.
80. Vedavanam K, Srijayanta S, O'Reilly J, et al. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 1999;13:601-8.
81. Cunnane SC, Ganguli S, Menard C, et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): Some nutritional properties in humans. Br J Nutr 1993;69:443-53.
82. Cunnane SC, Hamadeh MJ, Liede AC. et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995;61:62-8.
83. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipidemic humans with flaxseed supplementation: A preliminary report. Am Coll Nutr 1993;12:501-4.
84. Nestel PJ, Pomeroy SE, Sasahara T, et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizabillty. Arterioscler Thromb Vasc Biol 1997;17:1163-70.
85. Kaminskas A, Levaciov M, Lupinovic V, Kuchinskene Z. The effect of linseed oil on the fatty acid composition of blood plasma low- and very low-density lipoproteins and cholesterol in diabetes. Vopr Pitan 1992;5-6:13-4.
86. Jenkins DJA, Kendall CWC, Vidgen E, et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: A controlled crossover trial. Am J Clin Nutr 1999;69:395-402.
87. Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alphalinolenic acid. Atherosclerosis 1998;136:367-75.
88. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999:99:1355-62.
89. Xue JY, Liu GT, Wei HL, Pan Y. Antioxidant activity of two dibenzocyclooctene lignans on the aged and ischemic brain in rats. Free Radic Biol Med 1992;12:127-35.
90. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 1997;168:117-23.
91. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 2000;9:220-5.
92. Prasad K, Mantha SV, Muir AD, Westcott ND. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 2000;206:141-9.
93. Prasad K. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: Effect of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 2000;209:89-96.
94. Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 2001;138:32-9.
95. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45:399-405.
96. Crandall DL, Busler DE, Novak TJ, et al. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem Biophys Res Commun 1998;248:523-6.
97. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
98. Okura A, Arakawa H, Oka H, et al. Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988;157:183-9.
99. Markovits J, Linassier C, Fosse P, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989;49:5111-7.
100. Linassier C, Pierre M, LePecq J-B, Pierre J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 1990;39:187-93.
101. Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 2000;75:265-71.
102. Nogowski L, Mackowiak P, Kandulska K, et al. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 1998;42:360-6.
103. Mackowiak P, Nagowski L, Nowak KW. Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats. J Recept Signal Transduct Res 1999;19:283-92.
104. Persaud SJ, Harris TE, Burns CJ, Jones PM. Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets. J Mol Endocrinol 1999;22:19-28.
105. Abler A, Smith JA, Randazzo PA, et al. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 1992;267:3946-51.
106. Huppertz C, Fischer BM, Kim YB, et al. Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositicle 3-kinase-dependent mechanism. J Biol Chem 2001;276:2520-9.
107. Beguin DP, Kincaid RL. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase activity in chicks fed coumestrol, a phytoestrogen. Poult Sci 1984;63:686-90.
108. Fedorak RN, Cheeseman CI, Thomson BR, Porter VM. Altered glucose carrier expression: Mechanism of intestinal adaptation during streptozotocin-induced diabetic rats. Am J Physiol 1991;261:G585-91.
109. Burant CF, Flink S, DePaoli AM, et al. Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J Clin Invest 1994;93:578-85.
110. Sorenson RL, Brelje TC, Roth C. Effect of tyrosine kinase inhibitors on islets of Langerhans: Evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 1994;134:1975-8.
111. Hisatomi M, Hayakawa T, Hidaka H, Niki I. Modulation of tyrosine kinase activity has multiple actions on insulin release from the pancreatic beta-cell: Studies with lavendustin A. Jpn J Pharmacol 1997;74:203-8.
112. Verspohl EJ, Tollkuhn B, Kloss H. Role of tyrosine kinase in insulin in an insulin secreting cell line (INS-1). Cell Signal 1995;7:505-12.
113. Jones PM, Pesaud SJ. Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion. Biochem Soc Trans 1994;22:209S.
114. Ohno T, Kato N, Ishii C, et al. Genistein augments cyclic adenosine 3′5′-monophosphate (cAMP) accumulation and insulin release in MIN6 cells. Endocr Res 1993;19:273-85.
115. Nogowski L, Nowak KW, Mackowiak P. Effect of phytoestrogencoumestrol and oestrone on some aspects of carbohydrate metabolism in ovariectomized female rats. Arch Vet Pol 1992;32:79-84.